ERYTHROCYTE AGGREGATION AND LEUKOCYTE ISOLATION
    1.
    发明公开
    ERYTHROCYTE AGGREGATION AND LEUKOCYTE ISOLATION 审中-公开
    红霉素治疗白血病

    公开(公告)号:EP3176579A1

    公开(公告)日:2017-06-07

    申请号:EP16200924.5

    申请日:2016-11-28

    IPC分类号: G01N33/49

    摘要: A device 100 and/or methodology are described that include a mechanism for separating erythrocytes 110 from other constituents of blood and for purifying leukocytes 102 from blood. The separation and purification aspects may be provided in separate components or within the same component. The separation aspect assists in separating erythrocytes 110 (red blood cells) from other cells in blood, such as by aggregation of the red blood cells. A suitable aggregation device 100 or device component uses chambers with at least one small dimension (e.g., a microfluidic chip) to control the interaction of the blood with a solution containing a high molecular weight polymer (e.g., dextran) to achieve separation.

    摘要翻译: 描述了一种装置100和/或方法,其包括用于从血液的其它成分分离红细胞110并用于从血液净化白细胞102的机制。 分离和纯化方面可以在单独的组分中或同一组分内提供。 分离方面有助于将红细胞110(红细胞)与血液中的其它细胞分离,例如通过红细胞的聚集。 合适的聚集装置100或装置部件使用具有至少一个小尺寸的腔室(例如,微流体芯片)来控制血液与含有高分子量聚合物(例如葡聚糖)的溶液的相互作用以实现分离。